Reinisch, Mattea http://orcid.org/0000-0002-1381-8595
Kuemmel, Sherko http://orcid.org/0000-0001-9355-494X
Breit, Elisabeth http://orcid.org/0000-0002-1677-0005
Theuerkauf, Ingo
Harrach, Hakima
Schindowski, Dorothea
Moka, Detlef
Bettstetter, Marcus
Bruzas, Simona
Chiari, Ouafaa
Article History
Received: 27 April 2021
Accepted: 27 July 2021
First Online: 16 August 2021
Declarations
:
: According to ยง15 of the Nordrhein-Westfalen (Germany) Medical Association professional code of conduct, retrospective studies do not require ethics committee approval. Patients provided written informed consent.
: The two patients presented here agreed to their anonymous data being published and shared.
: SK reports personal fees from Lilly, Roche, Genomic Health, Novartis, Amgen, Celgene, Daiichi Sankyo, AstraZeneca, Somatex, MSD, Pfizer, Puma Biotechnology, PFM medical, non-financial support from Roche, Daiichi Sankyo, Lilly, and Sonoscape, outside the submitted work. SK is co-director of the WSG Study group. MR reports personal fees and travel support from Novartis and from Pfizer, personal fees from Somatex, MSD, AstraZeneca, Roche, Lilly and Seagen, travel support from Celgene, outside the submitted work. EB reports personal fees from Sysmex, Olympus, Merck Serono, and Daiichi Sankyo, outside the submitted work. All other authors have nothing to disclose.